Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease

Citation
A. Papassotiropoulos et al., Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease, MOL PSYCHI, 5(2), 2000, pp. 213-215
Citations number
9
Categorie Soggetti
Neurosciences & Behavoir
Journal title
MOLECULAR PSYCHIATRY
ISSN journal
13594184 → ACNP
Volume
5
Issue
2
Year of publication
2000
Pages
213 - 215
Database
ISI
SICI code
1359-4184(200003)5:2<213:COTABB>2.0.ZU;2-L
Abstract
Bleomycin hydrolase (BH), a cysteine protease from the papain superfamily, is considered to be a candidate for the beta-secretase, which is presumably involved in the production of beta-amyloid peptide. The G/G genotype of BH was identified as a significant risk factor for the development of Alzheim er's disease (AD) in subjects not carrying the apolipoprotein E epsilon 4 a llele (apoE-epsilon 4). However, this finding was recently challenged. We s tudied this polymorphism in a homogenous sample of German AD patients and c ontrols. The over-representation of the G/G genotype in AD patients could b e confirmed, however it was more pronounced in apoE-epsilon 4 carriers. Add itional studies should be undertaken to increase the confidence that the BH polymorphism is associated with AD and to explore the relationship between BH and apoE.